VARICELLA ZOSTER VIRUS VACCINE

Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS...

Full description

Saved in:
Bibliographic Details
Main Authors STEPHENNE, JEAN, HANON, EMMANUEL JULES
Format Patent
LanguageEnglish
French
Published 27.03.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Use of an immunogenic composition comprising VZV gE, or immunogenic fragment thereof, and a TH-1 adjuvant in the preparation of a medicament for the prevention or amelioration of shingles and/or post herpetic neuralgia. Compositions comprising a truncated VZV gE antigen and an adjuvant containing QS21, cholesterol and 3D MPL are also claimed. Lutilisation dune composition immunogène comprenant VZV gE, ou un fragment immunogène de celui-ci, et un adjuvant TH-1 dans la préparation dun médicament pour la prévention ou lamélioration du zona ou de la névralgie post-herpétique. Des compositions contenant un antigène tronqué de VZV gE et un adjuvant contenant QS21, cholestérol et 3D MP sont également revendiquées.
Bibliography:Application Number: CA20062882255